Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
faktor viii- inhibitorer - pup
factor viii inhibitors - pups
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
faktor viii- inhibition (pup)
factor viii inhibition (pups)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
det finns otillräckliga data för att ge information om incidensen av inhibitorer hos pup.
there are insufficient data to provide information on inhibitor incidence in pups.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
hos pup utvärderades de farmakokinetiska parametrarna för refacto med hjälp av den kromogena substratmetoden.
in pups, pharmacokinetic parameters of refacto were evaluated using the chromogenic assay.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
kliniska data för refacto af hos tidigare obehandlade patienter (pup) saknas.
6 there are no clinical data on previously untreated patients (pups) with refacto af.
Last Update: 2012-04-11
Usage Frequency: 4
Quality:
dock är kliniska studier med refacto af hos tidigare obehandlade patienter (pup) planerade.
however, clinical trials are planned in previously untreated patients (pups) with refacto af.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
farmakokinetisk populationsmodellering med hjälp av data från 44 pup gav en genomsnittlig uppskattad halveringstid på 8, 0 ± 2, 2 timmar.
population pharmacokinetic modeling using data from 44 pups led to a mean estimated half-life of 8.0 ± 2.2 hours.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
som en del av den pivotala studien med refacto hos pup granskades data om iti från 25 patienter (se avsnitt 4.8).
as part of the pivotal trial with refacto in pups, iti data from 25 patients were reviewed (see section 4.8).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
5 av 37 (14%) pup och 4 av 23 (17%) mtp patienter behandlade med helixate nexgen utvecklade inhibitorer:
five out of 37 (14%) pup and 4 out of 23 (17%) mtp patients treated with helixate nexgen developed inhibitors:
Last Update: 2012-04-11
Usage Frequency: 2
Quality: